<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A conditional mutant of Epstein-Barr virus nuclear antigen 2 (EBNA2) regulated by <z:chebi fb="0" ids="50114">estrogen</z:chebi> was employed to study the effect of EBNA2 on the <z:mp ids='MP_0005384'>cellular phenotype</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>Activation of EBNA2 in lymphoblastoid cell lines (LCLs) and in B cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> lines resulted in down-regulation of cell surface IgM and Ig-mu steady-state <z:chebi fb="40" ids="33697">RNA</z:chebi> expression </plain></SENT>
<SENT sid="2" pm="."><plain>In LCLs, activation of EBNA2 is required for maintaining proliferation, whereas in Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>) cell lines with t(8;14) translocations, activation of EBNA2 induces <z:mpath ids='MPATH_73'>growth arrest</z:mpath> </plain></SENT>
<SENT sid="3" pm="."><plain>In these cells, Northern and nuclear run-on analyses revealed rapid simultaneous repression of Ig-mu and c-myc transcription as early as 30 min after activation of EBNA2 </plain></SENT>
<SENT sid="4" pm="."><plain>Since c-myc expression is under the control of the Ig heavy chain locus in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> cell lines with a t(8;14) translocation, we propose that Ig-mu and c-myc are down-regulated by EBNA2 through a common mechanism </plain></SENT>
</text></document>